对慢性阻塞性肺疾病患者实施抗焦虑治疗的必要性研究  

Study on the necessity of antianxiety therapy in patients with chronic obstructive pulmonary disease

作　　者：孙春娟 SUN Chun-juan(Department of Respiratory and Critical Care Medicine,Wuhai People’s Hospital,Wuhai 016000,China)

机构地区：[1]内蒙古乌海市人民医院呼吸与危重症医学科,016000

出　　处：《中国实用医药》2020年第28期16-18,共3页China Practical Medicine

摘　　要：目的对慢性阻塞性肺疾病(COPD)患者实施抗焦虑治疗,分析其应用效果。方法98例COPD患者,采取随机数字表法分为观察组与对照组,各49例。对照组采取常规治疗,观察组在对照组基础上实施抗焦虑治疗。比较两组临床疗效、肺功能指标[第1秒用力呼气容积占用力肺活量的比值(FEV1/FVC)、FEV1占预计值的比值(FEV1%)、呼气峰值流速(PEF)、通气/血流灌注比值(V/Q)]、焦虑抑郁症状评分。结果观察组患者的治疗总有效率为97.96%,高于对照组的79.59%,差异有统计学意义(P<0.05)。治疗后,观察组患者的FEV1/FVC、FEV1%、PEF、V/Q分别为(60.49±7.07)%、(54.20±4.34)%、(3.30±0.51)L/s、(80.81±5.45)%,均高于对照组的(53.33±6.58)%、(50.01±3.33)%、(2.88±0.46)L/s、(74.01±4.36)%,差异有统计学意义(P<0.05)。治疗后,观察组患者的焦虑、抑郁评分分别为(7.62±1.08)、(8.02±0.97)分,均低于对照组的(12.20±2.10)、(12.29±2.03)分,差异有统计学意义(P<0.05)。结论对COPD患者实施抗焦虑治疗可提高治疗总有效率,改善患者焦虑抑郁症状及肺功能,值得推广。Objective To analyze the practical effect of antianxiety therapy in patients with chronic obstructive pulmonary disease(COPD).Methods A total of 98 COPD patients were divided into observation group and control group according to random numerical table,with 49 cases in each group.The control group was treated with conventional therapy,and the observation group was treated with antianxiety therapy on the basis of the control group.The clinical efficacy,pulmonary function[forced expiratory volume in the first second 1 forced vital capacity(FEV1/FVC),FEV1 to predicted value(FEV1%),peak respiratory flow(PEF),ventilation/perfusion ratio(V/Q)]and anxiety and depression symptom score were compared between the two groups.Results The total effective rate of treatment of the observation group was 97.96%,which was higher than 79.59%of the control group,and the difference was statistically significant(P<0.05).After treatment,FEV1,FEV1%,PEF and V/Q of the observation group were(60.49±7.07)%,(54.20±4.34)%,(3.30±0.51)L/s and(80.81±5.45)%respectively,which were higher than(53.33±6.58)%,(50.01±3.33)%,(2.88±0.46)L/s and(74.01±4.36)%of the control group,and the difference was statistically significant(P<0.05).After treatment,the anxiety and depression score of the observation group were(7.62±1.08)and(8.02±0.97)points,which were lower than(12.20±2.10)and(12.29±2.03)points of the control group,and the difference was statistically significant(P<0.05).Conclusion Antianxiety therapy can improve the therapeutic effect of COPD patients and improve the anxiety and depression symptoms and pulmonary function,which is worthy of promotion.

关 键 词：焦虑 慢性阻塞性肺疾病 肺功能 

分 类 号：R563.9[医药卫生—呼吸系统]